+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Sleep Apnea Devices Market Report and Forecast 2023-2031

  • PDF Icon


  • 140 Pages
  • May 2023
  • Region: Global
  • Expert Market Research
  • ID: 5797991
The global sleep apnea device market size attained a value of USD 9.6 billion in 2022. The market is anticipated to grow at a CAGR of 6.50% during the forecast period of 2023-2031 to reach a value of USD 17 billion by 2031.

Sleep Apnea Device Market: Introduction

A sleep apnea device is a medical apparatus designed to treat sleep apnea, a disorder characterized by repeated pauses in breathing or shallow breaths during sleep. These pauses, known as apneas or hypopneas, disrupt normal sleep patterns and can lead to poor sleep quality, daytime fatigue, and long-term health complications if left untreated. The most common type of sleep apnea device is the Continuous Positive Airway Pressure (CPAP) machine, which delivers a steady stream of air through a mask worn over the nose and/or mouth, keeping the airway open and preventing the collapse of soft tissues that cause breathing disruptions.

Other types of sleep apnea devices include Bi-level Positive Airway Pressure (BiPAP) machines, which provide varying levels of pressure for inhalation and exhalation, and Adaptive Servo-Ventilation (ASV) devices, which adjust airflow based on the user's breathing patterns. Additionally, oral appliances, such as mandibular advancement devices (MADs) and tongue retaining devices (TRDs), can be used to reposition the lower jaw or tongue, helping to maintain an open airway during sleep.

Sleep apnea devices are primarily used to improve sleep quality, reduce daytime fatigue, and prevent long-term health complications associated with untreated sleep apnea, such as hypertension, heart disease, stroke, and diabetes. By ensuring continuous airflow and maintaining open airways, these devices aim to minimize the occurrence of apneas and hypopneas, resulting in a more restful and healthier sleep.

Sleep Apnea Device Market Segmentations

The market can be categorised into diagnosis method, therapeutic devices, end user, and major region.

Market Breakup by Diagnosis Method

  • Polysomnography Devices (PSG)
  • Ambulatory PSG Devices
  • Clinical PSG Devices
  • Oximeters
  • Fingertip Oximeters
  • Handheld Oximeters
  • Wrist-worn Oximeter
  • Tabletop Oximeter
  • Home Sleep Testing Devices
  • Actigraphy Devices
  • Others

Market Breakup by Therapeutic Devices

  • Oxygen Devices
  • Oxygen Concentrators
  • Portable Oxygen Concentrators
  • Liquid Portable Oxygen
  • Oral Appliances Therapeutic Devices
  • Adaptive Servo Ventilation (ASV) Devices
  • Masks and Accessories

Market Breakup by End User

  • Sleep Laboratories and Hospitals
  • Clinics
  • Homecare Settings/Individuals
  • Others

Sleep Apnea Device Market Breakup by Region

North America

  • United States of America
  • Canada


  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others
Sleep Apnea Device Market
The sleep apnea device market has been experiencing significant growth due to a variety of factors. The rising prevalence of sleep apnea, coupled with an increasing awareness of its health risks and complications, has led to a greater demand for effective treatment options. Additionally, the aging global population and the growing prevalence of obesity, both of which are risk factors for sleep apnea, contribute to the expansion of the market.

Technological advancements in sleep apnea devices have resulted in more compact, comfortable, and user-friendly designs, which has further fuelled their adoption. Innovations in connectivity and data analysis capabilities have also improved patient monitoring and compliance, making these devices more appealing to both patients and healthcare providers.

Moreover, the expansion of home-based care and telemedicine has driven the demand for sleep apnea devices that can be used in non-clinical settings, allowing patients to manage their condition from the comfort of their homes. Finally, government initiatives, public health campaigns, and favorable reimbursement policies in many countries have played a crucial role in promoting the use of sleep apnea devices and making them more accessible to patients.

In summary, the sleep apnea device market is experiencing growth due to factors such as increased disease prevalence, technological advancements, an aging global population, rising obesity rates, and supportive government policies.

Key Players in the Global Sleep Apnea Device Market

The report gives an in-depth analysis of the key players involved in the sleep apnea device market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
  • Fisher & Paykel Healthcare Limited
  • Invacare Corporation
  • Natus Medical Incorporated
  • Cadwell Industries Inc
  • Vyaire Medical, Inc
  • Nihon Kohden Corporation
  • Koninklijke Philips N.V
  • ResMed Corp
  • Somnomed
  • Compumedics
  • Drive Devilbiss Healthcare
  • Lowenstein Medical Technology Gmbh
  • BMC Medical Co., Ltd.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Sleep Apnea Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
5 Global Sleep Apnea Device Market Overview
5.1 Global Sleep Apnea Device Market Historical Value (2016-2022)
5.2 Global Sleep Apnea Device Market Forecast Value (2023-2031)
6 Global Sleep Apnea Device Market Landscape
6.1 Global Sleep Apnea Device Developers Landscape
6.1.1 Analysis by Year of Establishment
6.1.2 Analysis by Company Size
6.1.3 Analysis by Region
6.2 Global Sleep Apnea Device Product Landscape
6.2.1 Analysis by Diagnosis Method
6.2.2 Analysis by End User
6.2.3 Analysis by Therapeutic Devices
7 Sleep Apnea Challenges and Unmet Needs
7.1 Treatment Pathway Challenges
7.2 Compliance and Drop-Out Analysis
7.3 Awareness and Prevention Gaps
8 Cost of Treatment
9 Global Sleep Apnea Device Market Dynamics
9.1 Market Drivers and Constraints
9.2 SWOT Analysis
9.3 Porter’s Five Forces Model
9.4 Key Demand Indicators
9.5 Key Price Indicators
9.6 Industry Events, Initiatives, and Trends
9.7 Value Chain Analysis
10 Global Sleep Apnea Device Market Segmentation
10.1 Global Sleep Apnea Device Market by Diagnosis Method
10.1.1 Market Overview
10.1.2 Polysomnography Devices (PSG) Ambulatory PSG Devices Clinical PSG Devices
10.1.3 Oximeters Fingertip Oximeters Handheld Oximeters Wrist-worn Oximeter Tabletop Oximeter
10.1.4 Home Sleep Testing Devices Actigraphy Devices Others
10.2 Global Sleep Apnea Device Market by Therapeutic Devices
10.2.1 Market Overview
10.2.2 Oxygen Devices Oxygen Concentrators Portable Oxygen Concentrators Liquid Portable Oxygen
10.2.3 Oral Appliances Therapeutic Devices
10.2.4 Adaptive Servo Ventilation (ASV) Devices
10.2.5 Masks and Accessories
10.3 Global Sleep Apnea Device Market by End User
10.3.1 Market Overview
10.3.2 Sleep Laboratories and Hospitals
10.3.3 Clinics
10.3.4 Homecare Settings/Individuals
10.3.5 Others
10.4 Global Sleep Apnea Device Market by Region
10.4.1 Market Overview
10.4.2 North America
10.4.3 Europe
10.4.4 Asia Pacific
10.4.5 Latin America
10.4.6 Middle East and Africa
11 North America Sleep Apnea Device Market
11.1 Market Share by Country
11.2 United States of America
11.3 Canada
12 Europe Sleep Apnea Device Market
12.1 Market Share by Country
12.2 United Kingdom
12.3 Germany
12.4 France
12.5 Italy
12.6 Others
13 Asia Pacific Sleep Apnea Device Market
13.1 Market Share by Country
13.2 China
13.3 Japan
13.4 India
13.5 ASEAN
13.6 Australia
13.7 Others
14 Latin America Sleep Apnea Device Market
14.1 Market Share by Country
14.2 Brazil
14.3 Argentina
14.4 Mexico
14.5 Others
15 Middle East and Africa Sleep Apnea Device Market
15.1 Market Share by Country
15.2 Saudi Arabia
15.3 United Arab Emirates
15.4 Nigeria
15.5 South Africa
15.6 Others
16 Patent Analysis
16.1 Analysis by Type of Patent
16.2 Analysis by Publication year
16.3 Analysis by Issuing Authority
16.4 Analysis by Patent Age
16.5 Analysis by CPC Analysis
16.6 Analysis by Patent Valuation
16.7 Analysis by Key Players
17 Grants Analysis
17.1 Analysis by year
17.2 Analysis by Amount Awarded
17.3 Analysis by Issuing Authority
17.4 Analysis by Grant Application
17.5 Analysis by Funding Institute
17.6 Analysis by NIH Departments
17.7 Analysis by Recipient Organization
18 Clinical Trials Analysis
18.1 Analysis by Trial Registration Year
18.2 Analysis by Trial Status
18.3 Analysis by Trial Phase
18.4 Analysis by Therapeutic Area
18.5 Analysis by Geography
19 Funding Analysis
19.1 Analysis by Funding Instances
19.2 Analysis by Type of Funding
19.3 Analysis by Funding Amount
19.4 Analysis by Leading Players
19.5 Analysis by Leading Investors
19.6 Analysis by Geography
20 Partnership and Collaborations Analysis
20.1 Analysis by Partnership Instances
20.2 Analysis by Type of Partnership
20.3 Analysis by Leading Players
20.4 Analysis by Geography
21 Regulatory Framework
21.1 Regulatory Overview
21.1.1 US FDA
21.1.2 EU EMA
21.1.5 Others
22 Supplier Landscape
22.1 Fisher & Paykel Healthcare Limited
22.1.1 Financial Analysis
22.1.2 Product Portfolio
22.1.3 Demographic Reach and Achievements
22.1.4 Mergers and Acquisitions
22.1.5 Certifications
22.2 Invacare Corporation
22.2.1 Financial Analysis
22.2.2 Product Portfolio
22.2.3 Demographic Reach and Achievements
22.2.4 Mergers and Acquisitions
22.2.5 Certifications
22.3 Natus Medical Incorporated
22.3.1 Financial Analysis
22.3.2 Product Portfolio
22.3.3 Demographic Reach and Achievements
22.3.4 Mergers and Acquisitions
22.3.5 Certifications
22.4 Cadwell Industries Inc.
22.4.1 Financial Analysis
22.4.2 Product Portfolio
22.4.3 Demographic Reach and Achievements
22.4.4 Mergers and Acquisitions
22.4.5 Certifications
22.5 Vyaire Medical, Inc.
22.5.1 Financial Analysis
22.5.2 Product Portfolio
22.5.3 Demographic Reach and Achievements
22.5.4 Mergers and Acquisitions
22.5.5 Certifications
22.6 Nihon Kohden Corporation
22.6.1 Financial Analysis
22.6.2 Product Portfolio
22.6.3 Demographic Reach and Achievements
22.6.4 Mergers and Acquisitions
22.6.5 Certifications
22.7 Koninklijke Philips N.V.
22.7.1 Financial Analysis
22.7.2 Product Portfolio
22.7.3 Demographic Reach and Achievements
22.7.4 Mergers and Acquisitions
22.7.5 Certifications
22.8 ResMed Corp.
22.8.1 Financial Analysis
22.8.2 Product Portfolio
22.8.3 Demographic Reach and Achievements
22.8.4 Mergers and Acquisitions
22.8.5 Certifications
22.9 Somnomed
22.9.1 Financial Analysis
22.9.2 Product Portfolio
22.9.3 Demographic Reach and Achievements
22.9.4 Mergers and Acquisitions
22.9.5 Certifications
22.10 Compumedics
22.10.1 Financial Analysis
22.10.2 Product Portfolio
22.10.3 Demographic Reach and Achievements
22.10.4 Mergers and Acquisitions
22.10.5 Certifications
22.11 Drive Devilbiss Healthcare
22.11.1 Financial Analysis
22.11.2 Product Portfolio
22.11.3 Demographic Reach and Achievements
22.11.4 Mergers and Acquisitions
22.11.5 Certifications
22.12 Lowenstein Medical Technology Gmbh
22.12.1 Financial Analysis
22.12.2 Product Portfolio
22.12.3 Demographic Reach and Achievements
22.12.4 Mergers and Acquisitions
22.12.5 Certifications
22.13 BMC Medical Co., Ltd.
22.13.1 Financial Analysis
22.13.2 Product Portfolio
22.13.3 Demographic Reach and Achievements
22.13.4 Mergers and Acquisitions
22.13.5 Certifications
23 Global Sleep Apnea Device Market- Distribution Model (Additional Insight)
23.1 Overview
23.2 Potential Distributors
23.3 Key Parameters for Distribution Partner Assessment
24 Key Opinion Leaders (KOL) Insights (Additional Insight)
25 Company Competitiveness Analysis (Additional Insight)
25.1 Very Small Companies
25.2 Small Companies
25.3 Mid-Sized Companies
25.4 Large Companies
25.5 Very Large Companies
26 Payment Methods (Additional Insight)
26.1 Government Funded
26.2 Private Insurance
26.3 Out-of-Pocket

Companies Mentioned

  • Fisher & Paykel Healthcare Limited
  • Invacare Corporation
  • Natus Medical Incorporated
  • Cadwell Industries Inc.
  • Vyaire Medical, Inc.
  • Nihon Kohden Corporation
  • Koninklijke Philips N.V.
  • Resmed Corp.
  • Somnomed
  • Compumedics
  • Drive Devilbiss Healthcare
  • Lowenstein Medical Technology GmbH
  • Bmc Medical Co. Ltd.



Table Information